Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
1. |
ECCT/26/06/01 | SANDLY A Phase 1, Multi-Site, Double-Blinded, Placebo-Controlled Dose-Escalation Study to Evaluate the Safety and Immunogenicity of Leishmania major LmCen -/- vaccine in healthy Kenyan and Brazilian Adults (SANDFLY) |
Principal Investigator(s) 1. JOSPHAT KOSGEI Site(s) in Kenya KEMRI WRP CRC KERICHO |
08-11-2026 |
View |
2. |
ECCT/26/06/03 | C1091009 - Study Site 1254 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Fredrick Kipyego Sawe Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project (Kericho county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
3. |
ECCT/26/06/02 | HibiscusJr A global phase 3 Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of etavopivat in children with Sickle Cell Disease. |
Principal Investigator(s) 1. Dr. Sharon Mokeira Ocharo Site(s) in Kenya 1. Victoria Biomedical Research Institute (Kisumu county) |
23-10-2026 |
View |
4. |
ECCT/26/05/01 | C1091009 Study site 1193 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Janet Nyawira Oyieko Site(s) in Kenya 1. KEMRI Butere Clinical Research Centre (Kakamega county) 2. Kenya Medical Research Institute Walter Reed Project (Kericho county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
5. |
ECCT/26/03/02 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. St Marys Mission Hospital-Langata (Nairobi City county) 2. Mbagathi County Referral Hospital (Nairobi City county) |
04-06-2026 |
View |
6. |
ECCT/26/03/03 | LIBRA A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group sequential, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib in patients aged 10 to 65 years with sickle-cell disease (LIBRA) |
Principal Investigator(s) 1. Jessie Githanga Site(s) in Kenya Getrudes’s Children\'s Hospital |
23-10-2026 |
View |
7. |
ECCT/26/03/01 | C1091009 Study A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya 1. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute Walter Reed Project (Kericho county) 4. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) |
26-08-2026 |
View |
8. |
ECCT/26/04/01 | ACRN-MNK02-301 A Phase 3, randomized, double-blind, placebo-controlled trial to evaluate the effect of Bifidobacterium longum subsp. infantis DSM33361(Bifin02) administered together with Lacticaseibacillus rhamnosus GG DSM33156 (LGG ®) versus placebo on weight gain in underweight infants. |
Principal Investigator(s) 1. Prof. Videlis Nduba Site(s) in Kenya 1. KEMRI-CRDR (Nairobi City county) 2. KEMRI-MTWAPA (Kilifi county) 3. Moi University Clinical Research Centre (Uasin Gishu county) |
21-10-2026 |
View |
9. |
ECCT/26/02/07 | IMPAACT 2024 Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV |
Principal Investigator(s) 1. LUCY Chepkurui Koech Site(s) in Kenya Kenya Medical Research Institute/Walter Reed Project(KEMRI/WRP) |
27-08-2026 |
View |
10. |
ECCT/26/02/02 | REVIVE Study - JOOTRH A randomised, double blinded, placebo-controlled, multicentre trial of azithromycin prophylaxis for advanced HIV disease |
Principal Investigator(s) 1. Loice Achieng Ombajo Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county) |
22-08-2026 |
View |